Rituxan and Biopsy bone marrow abnormal - a phase IV clinical study of FDA data

Summary:

Biopsy bone marrow abnormal is reported as a side effect among people who take Rituxan (rituximab), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Prednisone, and have Dermatitis.

The phase IV clinical study analyzes which people have Biopsy bone marrow abnormal when taking Rituxan. It is created by eHealthMe based on reports of 64,282 people who have side effects when taking Rituxan from the FDA, and is updated regularly.

What is Rituxan?

Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. eHealthMe is studying from 64,791 Rituxan users. Check the latest studies of Rituxan.

What is Biopsy bone marrow abnormal?

Biopsy bone marrow abnormal is found to be associated with 282 drugs and 271 conditions by eHealthMe. Check the latest studies of Biopsy bone marrow abnormal.

On Jul, 14, 2026

64,282 people reported to have side effects when taking Rituxan.
Among them, 30 people (0.05%) have Biopsy bone marrow abnormal.

Could Rituxan cause Biopsy bone marrow abnormal?

Among these 30 people:

How long have people been on Rituxan when they have Biopsy bone marrow abnormal? *

What is the gender of people who have Biopsy bone marrow abnormal when taking Rituxan? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Biopsy bone marrow abnormal when taking Rituxan? *

What are other drugs people take besides Rituxan? *

What are other side effects people have besides Biopsy bone marrow abnormal? *

Night Sweats (sweating in night): 10 people, 33.33%
Weakness: 9 people, 30.00%
Anaemia (lack of blood): 8 people, 26.67%
Insomnia (sleeplessness): 8 people, 26.67%
Urinary Tract Infection: 7 people, 23.33%
Weight Decreased: 7 people, 23.33%
White Blood Cell Count Decreased: 6 people, 20.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 20.00%
Gastritis (inflammation of stomach): 6 people, 20.00%
Herpes Zoster: 6 people, 20.00%

What are the existing conditions these people have? *

Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 6 people, 20.00%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 5 people, 16.67%
Prolymphocytic Leukaemia (cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells): 4 people, 13.33%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 10.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 6.67%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 6.67%
Osteoporosis (bones weak and more likely to break): 1 person, 3.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 3.33%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 3.33%
Hodgkin's Disease Lymphocyte Predominance Type Stage Unspecified (cancer originating from white blood cells -stage unspecified): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Rituxan and have Biopsy bone marrow abnormal?

- Check whether Biopsy bone marrow abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rituxan:

Rituxan (64,791 reports)

Browse all side effects of Rituxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Biopsy bone marrow abnormal:

Biopsy bone marrow abnormal (282 drugs)

Browse all the conditions that are associated with Biopsy bone marrow abnormal:

Biopsy bone marrow abnormal (271 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rituximab (the active ingredients of Rituxan) and Rituxan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.